| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 09/01/2004 | CN1164583C Separating preparing technology of gallo catechin and gallate |
| 09/01/2004 | CN1164326C Deoxidation type glutathione lozenge |
| 08/31/2004 | US6782891 Process for the isolation of a major harmful oxidant from cigarette smoke |
| 08/26/2004 | WO2004071639A2 Per (3,6-anhydro) cyclodextrine derivatives, production and use thereof in transporting metal elements to biological targets or in order to decontaminate biological fluids or targets |
| 08/26/2004 | WO2004071416A2 Novel inhibitors of formation of advanced glycation endproducts (ages) |
| 08/26/2004 | US20040167330 Suitable targeting moieties are monoclonal antibodies, their fragments and recombinant derivatives such as single chain antibodies, diabodies, triabodies, humanized, human or chimeric variants but also peptides, aptamers, spiegelmers, nucleotides, anti sense oligomers |
| 08/25/2004 | EP1448557A2 Heteroindanes: a new class of potent cannabimimetic ligands |
| 08/25/2004 | EP1448127A1 Compositions for the treatment of infectious diseases |
| 08/25/2004 | EP1448056A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/24/2004 | US6780970 Peptides for use in the treatment and prevention of diabetes, reperfusion injuries, immunological, cardiovascular and autoimune diseases |
| 08/24/2004 | US6780888 Fat-soluble and stable silicon-containing derivatives of ascorbic acid |
| 08/24/2004 | US6780886 Administering 2,5,7,8-tetramethyl-2-( beta-carboxyethyl)-6-hydroxychromane, or 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychromane; treating arteriosclerosis, disease caused by oxidated low density lipoprotein |
| 08/24/2004 | US6780884 Derivating of tryptamine and analogous compounds and pharmaceutical formulations containing them |
| 08/24/2004 | US6780870 Treatment of the pain (both chronic and acute), fever and inflammation of a variety of conditions and diseases mediated by cox-2 |
| 08/24/2004 | US6780442 Efficient method for producing compositions enriched in anthocyanins |
| 08/24/2004 | US6780416 Bee venom polypeptides and methods of use thereof |
| 08/19/2004 | WO2004069806A2 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds |
| 08/19/2004 | US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 08/19/2004 | CA2514028A1 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds |
| 08/18/2004 | EP1324809A4 Process for selectively extracting bioactive components |
| 08/18/2004 | CN1520864A Multifunctional antidote for snake-bites |
| 08/18/2004 | CN1162150C Theopolyphenol composition for injection and its preparing process |
| 08/17/2004 | CA2212010C Extracts of shark cartilage, process of production and uses thereof |
| 08/12/2004 | WO2004067678A1 Antioxidative composition and composition for external use |
| 08/12/2004 | US20040158092 for example, N-(N-acetyl-L-cysteinyl)-S-acetylcysteamine; by protecting the N-acyl-L-cysteine to form an intermediate compound and then coupling intermediate compound with S-acylcysteamine hydrochloride or with thiazolidine |
| 08/12/2004 | US20040157914 Pyrrolidinone derivatives |
| 08/12/2004 | US20040157791 Systemic immune activation method using nucleic acid-lipid complexes |
| 08/12/2004 | US20040157783 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 08/12/2004 | US20040156929 Rice cultivar C3GHi |
| 08/11/2004 | EP1444229A1 Pyrazole derivatives as psychopharmaceuticals |
| 08/11/2004 | EP1443962A2 Method for the treatment of cardiotoxicity induced by antitumor compounds |
| 08/11/2004 | EP1443948A1 Process for the preparation of anthocyanin-containing products |
| 08/11/2004 | EP1443924A1 4-[3,5-bis-(2-hydroxy-phenyl)-[1,2,4]triazol-1-yl]-benzoic acid derivatives for treating an excess of metal in the body |
| 08/11/2004 | CN1520291A Fumaric acid derivatives as NF-Kappab inhibitors |
| 08/11/2004 | CN1519023A Iso saponin capsule of superoxide dismutase |
| 08/11/2004 | CN1161113C Methods for treatment of neuro-and nephro-disorders and therapeutic toxicities using aminothiol compounds |
| 08/05/2004 | WO2004064543A1 Compositions containing coenzyme q10 |
| 08/05/2004 | WO2003103590A3 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | US20040152960 Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug |
| 08/05/2004 | US20040152761 Dimeric isoflavones |
| 08/05/2004 | US20040152157 G-protein coupled receptors |
| 08/05/2004 | DE10304374A1 Neue substituierte 2-Aminoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament New substituted 2-Aminoimidazole, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing |
| 08/04/2004 | EP1443108A2 Processes for preparing reconstructed skin supplemented in ceramid 7 and/or 5.5, composition based on lamellar lipid vesicles comprising a derivative of ceramid 7 and/or 5.5 and use thereof |
| 08/04/2004 | EP1442740A1 Use of N-arylmethylene ethylenediamine triacetates, N-arylmethylene iminodiacetates or N, N'-diarylmethylene ethylenediamine diacetates as NO donors |
| 08/04/2004 | EP1441738A1 A combination product comprising melagatran and dexamethasone |
| 08/04/2004 | EP1441725A1 Benzimidazoles and analogues and their use as protein kinases inhibitors |
| 08/04/2004 | EP1441718A2 Carbinols for the treatment of neuropathic dysfunction |
| 08/04/2004 | EP1296945B1 Sulfonamide derivatives |
| 08/04/2004 | EP1150658B1 Method for controlling liposome size |
| 08/04/2004 | CN1517097A Bambbo leaf flavone freeze dried powser injection, its preparation method and application |
| 08/04/2004 | CN1160352C Three-site substituted beta-carboline novel compound having anti-HIV and anti-cancer activity, preparation method and its composition and use |
| 08/04/2004 | CN1160344C Compounds for treatment of asthma, allergy and inflammatory disorders and its use |
| 08/04/2004 | CN1160068C Inihibition of lipoprotein oxidation |
| 08/03/2004 | CA2456035A1 Use of n-ary n-arylmethyleneiminodiacetates or n, n1-diarylmethylene ethylenediamineacetates as sources of no lmethylene ethylenediaminetriacetates |
| 07/29/2004 | WO2004062659A1 Methods and compositions for preventing/reducing the severity of side effects of chemotherapy and/or radiotherapy |
| 07/29/2004 | US20040147614 Serotonin receptor antagonist; administering reboxetine; psychological disorders |
| 07/29/2004 | US20040147610 Aging resistance; anticancer agents; neurodegradation disease;amyotropic lateral sclerosis; Alzheimer's disease |
| 07/29/2004 | US20040147497 N-formyl derivatives of paroxetine |
| 07/28/2004 | EP1440692A1 Medical adsorbent and process for production thereof |
| 07/28/2004 | EP1440687A1 Antiradicals and fat compositions, foods, drinks, drugs or feeds containing the antiradicals |
| 07/28/2004 | EP1440091A1 Nogo receptor homologues and their use |
| 07/28/2004 | EP1440073A1 Pde9 inhibitors for treating cardiovascular disorders |
| 07/28/2004 | EP1440067A1 N-formyl derivatives of paroxetine |
| 07/28/2004 | EP1439863A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 07/28/2004 | EP1439858A1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions |
| 07/28/2004 | EP1439842A1 Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance |
| 07/28/2004 | EP1439831A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/28/2004 | CN1516698A Arylindenopyridines with PDE inhibiting activity |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1159062C Pharmaceutical compositions of peptides having low solubility in physiological medium |
| 07/28/2004 | CN1159019C Extractable compounds and method for making and using the same |
| 07/28/2004 | CN1159010C Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
| 07/27/2004 | US6767555 A cyclosporin-containing composition in the form of a capsule consists of a polyoxyethylene sorbitan fatty acid ester, a reaction product of a natural or hydrogenated castor oil, ethylene oxide, a sorbitan fatty ester, and ethanol |
| 07/27/2004 | US6767533 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 07/27/2004 | US6767531 High dose radionuclide complexes for bone marrow suppression |
| 07/27/2004 | US6767326 Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug |
| 07/22/2004 | WO2004060490A1 Composition comprising a desferrioxamine-metal complex and its use for treating tissue damage following exposure to warfare agent |
| 07/22/2004 | WO2004060401A1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 07/22/2004 | US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity |
| 07/22/2004 | US20040142908 Cytoprotection by means of phosphotyrosine |
| 07/22/2004 | US20040141963 Medical adsorbent and process for production of the same |
| 07/22/2004 | US20040141912 Administering medicinally-useful agent which is phospholipid scramblase (PLS)-dependent transported compound to cells, thereby causing selective transport of agent into cells |
| 07/22/2004 | CA2708895A1 Compositions, methods and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 07/22/2004 | CA2507971A1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 07/21/2004 | EP1438299A1 Bifunctional chelating agent for actinium |
| 07/21/2004 | EP1438058A1 Extract of ceratonia siliqua leaves and pods containing polyphenols with antioxidant and antitumor activities |
| 07/21/2004 | EP1437945A1 Use of cystathionine |
| 07/21/2004 | EP1292608B1 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 07/21/2004 | EP1200110A4 In vivo induction for enhanced function of isolated hepatocytes |
| 07/21/2004 | CN1514730A Excretion accelerator for accumulative chlorine compound |
| 07/21/2004 | CN1513503A Medicinal composition for preventing and treating lead toxication |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/20/2004 | US6764683 Stimulation of hematopoiesis in patients undergoing cytotoxic cancer chemotherapy; preventing mucositis; cytoprotection |
| 07/20/2004 | CA2396927C Stabilized ascorbic acid solutions; use thereof; process for their obtention; and formulations comprising the same |
| 07/15/2004 | US20040138194 Hormone replacement therapy |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/14/2004 | EP1437139A2 Method for protection against genotoxic mutagenesis |
| 07/14/2004 | EP1437133A1 Amines with antialcoholic agents |